Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer
暂无分享,去创建一个
R. Simon | M. Kluth | C. Hube-Magg | K. Rothkamm | P. Tennstedt | C. Oing | E. Dikomey | W. Mansour | K. Borgmann | J. Volquardsen | C. Petersen